Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate.
The toxicity of available drugs for treatment of leishmaniasis, coupled with emerging drug resistance, make it urgent to find new therapies. Antimicrobial peptides (AMPs) have a strong broad-spectrum antimicrobial activity with distinctive modes of action and are considered as promising therapeutic...
Saved in:
Main Authors: | Sara Dabirian (Author), Yasaman Taslimi (Author), Farnaz Zahedifard (Author), Elham Gholami (Author), Fatemeh Doustdari (Author), Mahdieh Motamedirad (Author), Shohreh Khatami (Author), Kayhan Azadmanesh (Author), Susanne Nylen (Author), Sima Rafati (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.
by: Zahra Abdossamadi, et al.
Published: (2017) -
Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.
by: Farnaz Zahedifard, et al.
Published: (2019) -
Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.
by: Farnaz Zahedifard, et al.
Published: (2019) -
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.
by: Negar Seyed, et al.
Published: (2011) -
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
by: Farnaz Zahedifard, et al.
Published: (2014)